Response to "Association of IDH1/2 mutation with preoperative seizure in low-grade gliomas: How strong is the evidence?"

被引：2
|
作者：
Wang, Zheng [1 ,2 ,3 ,4 ]
Zhang, Zhong [4 ,5 ]
Wang, Yinyan [1 ,2 ,3 ,4 ]
You, Gan [1 ,2 ,4 ,6 ]
Jiang, Tao [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China
[2] Beijing Inst Brain Disorders, Beijing, Peoples R China
[3] Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China
[4] Chinese Glioma Genome Atlas Network, Beijing, Peoples R China
[5] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China
[6] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China
来源：
EPILEPSY RESEARCH | 2015年 / 115卷
关键词：
D O I：
10.1016/j.eplepsyres.2015.06.004
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：145 / 146
页数：2
相关论文
共 50 条
  • [31] IDH1 mutation is prognostic for diffuse astrocytoma but not low-grade oligodendrogliomas in patients not treated with early radiotherapy
    Yasuo Iwadate
    Tomoo Matsutani
    Seiichiro Hirono
    Shiro Ikegami
    Natsuki Shinozaki
    Naokatsu Saeki
    Journal of Neuro-Oncology, 2015, 124 : 493 - 500
  • [32] Construction of ceRNA networks with different types of IDH1 mutation status in low-grade glioma patients
    Wang, Wen-Jie
    Lu, Yu-Jie
    Li, Ying
    Tang, Jie-Qing
    Wang, Han
    Song, Wei
    Wang, Jing-Jing
    Huang, Yue-Qing
    Wang, Ying
    Lian, Lian
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (05)
  • [33] Histopathological malignant progression of grade II and III gliomas correlated with IDH1/2 mutation status
    Makoto Ohno
    Yoshitaka Narita
    Yasuji Miyakita
    Yoshiko Okita
    Yuko Matsushita
    Akihiko Yoshida
    Shintaro Fukushima
    Koichi Ichimura
    Takamasa Kayama
    Soichiro Shibui
    Brain Tumor Pathology, 2012, 29 : 183 - 191
  • [34] Histopathological malignant progression of grade II and III gliomas correlated with IDH1/2 mutation status
    Ohno, Makoto
    Narita, Yoshitaka
    Miyakita, Yasuji
    Okita, Yoshiko
    Matsushita, Yuko
    Yoshida, Akihiko
    Fukushima, Shintaro
    Ichimura, Koichi
    Kayama, Takamasa
    Shibui, Soichiro
    BRAIN TUMOR PATHOLOGY, 2012, 29 (04) : 183 - 191
  • [35] IDH1 mutation is prognostic for diffuse astrocytoma but not low-grade oligodendrogliomas in patients not treated with early radiotherapy
    Iwadate, Yasuo
    Matsutani, Tomoo
    Hirono, Seiichiro
    Ikegami, Shiro
    Shinozaki, Natsuki
    Saeki, Naokatsu
    JOURNAL OF NEURO-ONCOLOGY, 2015, 124 (03) : 493 - 500
  • [36] Prognostic significance of IDH mutation in adult low-grade gliomas: a meta-analysis
    Sun, Hairui
    Yin, Lianhu
    Li, Showwei
    Han, Song
    Song, Guangrong
    Liu, Ning
    Yan, Changxiang
    JOURNAL OF NEURO-ONCOLOGY, 2013, 113 (02) : 277 - 284
  • [37] Prognostic significance of IDH mutation in adult low-grade gliomas: a meta-analysis
    Hairui Sun
    Lianhu Yin
    Showwei Li
    Song Han
    Guangrong Song
    Ning Liu
    Changxiang Yan
    Journal of Neuro-Oncology, 2013, 113 : 277 - 284
  • [38] The Impact of IDH1 and IDH2 Mutations on Progression-Free and Overall Survival in Low Grade Gliomas
    Croul, Sidney
    Knobbe, Christiane
    Sabha, Nesrin
    von Deimling, Andreas
    Guha, Abhijit
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2011, 70 (06): : 500 - 500
  • [39] 2-HYDROXYGLUTARATE AS A BIOMARKER FOR IDH MUTATION IN LOW GRADE GLIOMAS
    Nejad, R.
    Sim, H.
    Aldape, K.
    Mason, W.
    Bernstein, M.
    Gentili, F.
    Kalia, S.
    Tung, T.
    Chen, E.
    Zadeh, G.
    NEURO-ONCOLOGY, 2017, 19 : 89 - 90
  • [40] TEXTILOMA RESEMBLING ANAPLASTIC PROGRESSION OF AN IDH1 MUTANT, LOW-GRADE GLIOMA
    Anderson, Mark D.
    Raghunathan, Aditya
    Aldape, Kenneth D.
    Fuller, Greg N.
    Gilbert, Mark R.
    NEURO-ONCOLOGY, 2012, 14 : 67 - 67
12345